Tuberculosis (TB) - blood test
Hospitals and CBRFs are the only two providers in Wisconsin for which the
TB skin test is specified in the requirements. For all other types of
licensed providers that require screening for infectious diseases (nursing
homes, facilities for the developmentally disabled, etc.), the TB skin test
is not specified. Thus, all other providers may also choose to screen for
tuberculosis infection using QFT-G in place of the TB skin test without any
special variance or waiver.
for using the QuantiFERON-TB Gold Test (QFT-G) for detecting Mycobacterium
tuberculosis infection, United States
WMMR, December 16, 2005 / 54(RR15);49-55 (exit DHS)
QuantiFERON®-TB Gold test (QFT-G), a
whole-blood test for use in detecting Mycobacterium tuberculosis infection, received Food and
Drug Administration (FDA) approval in 2005.
QFT-G may now
be used in ALL occupational settings
in place of a skin test.
Wisconsin Bureau of Quality Assurance has granted a statewide variance
any hospital or Community-based residential facility (CBRF) to use
an alternative to the Mantoux TB skin test for tuberculosis screening.
The Tuberculosis Program can provide additional information about the
use of QuantiFERON®-TB Gold in Wisconsin.
Facilities in/near Wisconsin offering QuantiFERON®-TB Gold
Facilities listed are provided for convenience purposes only.
Their use does not imply endorsement by the Wisconsin Department of Health Services.
Call the individual facility for details.
TB Home |
Admin. Rules |
National | Resources
Provider | Resources
Local Health Departments - Regional offices - Tribal agencies
Respiratory Diseases and International Health Unit
Division of Public Health
Bureau of Communicable Diseases and Emergency Response
1 West Wilson Street
Madison WI 53701-2659
Lorna Will -
Jo Mercurio -
Pa Vang - TB nurse consultant
Wegner - TB nurse consultant
August 07, 2014